Monday, 28 April 2014

On the chances of Sun turning around Ranbaxy

A short piece on Sun's chances with reviving Ranbaxy. Most analysts I spoke to thought the valuation was too high for a company with so many regulatory problems. http://forbesindia.com/article/big-bet/sun-has-a-better-shot-than-most-at-ranbaxy-turnaround/37664/1
Posted by at

2 comments:

  1. Abhishek6 May 2014 at 09:14

    Seems you were already on the story when we discussed it at Antargange :-)

    ReplyDelete
  2. Unknown19 June 2014 at 21:45

    That's right :)

    ReplyDelete

Subscribe to: Post Comments (Atom)